The upregulation of PD-L1 signifies a poor prognosis in NSCLC because it negatively regulates levels of CD4+ and CD8+ tumor-infiltrating T lymphocytes, which are associated with a better prognosis [12]. Here, CD8A is linked to neoplasm.